Carregant...
Multiple Myeloma: 2016 update on Diagnosis, Risk-stratification and Management
DISEASE OVERVIEW: Multiple myeloma accounts for approximately 10% of hematologic malignancies. DIAGNOSIS: The diagnosis requires ≥10% clonal bone marrow plasma cells or a biopsy proven plasmacytoma plus evidence of one or more multiple myeloma defining events (MDE): CRAB (hypercalcemia, renal failur...
Guardat en:
| Publicat a: | Am J Hematol |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5291298/ https://ncbi.nlm.nih.gov/pubmed/27291302 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.24402 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|